Cost-effectiveness assessment of orphan drugs: a scientific and political conundrum. (Q45960757)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

editorial

0 references

title

Cost-effectiveness assessment of orphan drugs: a scientific and political conundrum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

cost-effectiveness analysis

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Steven Simoens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Eline Picavet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Marc Dooms

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

David Cassiman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

1 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

Applied Health Economics and Health Policy

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40258-012-0004-y

22 February 2020

exact match

0 references

cites work

Pricing and reimbursement of orphan drugs: the need for more transparency

1 reference

https://api.crossref.org/works/10.1007%2FS40258-012-0004-Y

Orphan drugs for rare diseases: is it time to revisit their special market access status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-012-0004-Y

Ethical issues in funding orphan drug research and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-012-0004-Y

Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-012-0004-Y

10.1007/S40258-012-0004-Y

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23329382%20AND%20SRC:MED&resulttype=core&format=json